Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action.

The Lancet. Respiratory medicine - 1 Apr 2021

Yang Chengliang, Chapman Kenneth R, Wong Aaron, Liu Mingyao

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency
Share to Clinical Trials as Topic
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Drug Treatment

Share to Serine Endopeptidases

Share to Serine Proteinase Inhibitors

Share to Virus Internalization

Source

Open in PubMed Open full text

Identifiers

PMID: 33485406
DOI: 10.1016/S2213-2600(21)00018-7
PMCID: PMC7826115

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action.PMID 33485406Read ↗

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohortSemantic proximity Read ↗

Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rateSemantic proximity Read ↗

The human genetic epidemiology of COVID-19Semantic proximity Read ↗

Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration.Semantic proximity Read ↗

Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidenceSemantic proximity Read ↗

Genetic risks and association with severe COVID-19 among global populations.Semantic proximity Read ↗

An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case-control study.Semantic proximity Read ↗

Clinical Scenario Predicting the Genetic Susceptibility for Severity of COVID-19 Disease.Semantic proximity Read ↗

An integrated clinical and genetic model for predicting risk of severe COVID-19Semantic proximity Read ↗

Validation of a clinical and genetic model for predicting severe COVID-19Semantic proximity Read ↗

Role of the alpha-1 antitrypsin towards progression and severity of COVID- 19 infection among Saudi patientsSemantic proximity Read ↗

Susceptibility to severe COVID-19.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.